A New York drugmaker is set to begin a clinical trial of a new antibody treatment. A treatment of last resort: A virus patient is recovering from a double lung transplant.
Source: New York Times
A New York drugmaker is set to begin a clinical trial of a new antibody treatment. A treatment of last resort: A virus patient is recovering from a double lung transplant.
Source: New York Times